1. Home
  2. BANL vs PYPD Comparison

BANL vs PYPD Comparison

Compare BANL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

HOLD

Current Price

$0.44

Market Cap

11.7M

Sector

Energy

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.00

Market Cap

66.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANL
PYPD
Founded
2015
2008
Country
Malaysia
Israel
Employees
N/A
61
Industry
Oil Refining/Marketing
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
66.2M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
BANL
PYPD
Price
$0.44
$4.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
34.0K
85.1K
Earning Date
09-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$580,456,800.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.40
$2.30
52 Week High
$1.30
$4.07

Technical Indicators

Market Signals
Indicator
BANL
PYPD
Relative Strength Index (RSI) 40.30 58.21
Support Level $0.44 $3.94
Resistance Level $0.46 $4.07
Average True Range (ATR) 0.02 0.14
MACD 0.01 0.01
Stochastic Oscillator 66.26 68.09

Price Performance

Historical Comparison
BANL
PYPD

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: